Healthcare Mergers and Acquisitions for Hospitals and Providers

Hospital and health system transactions can include:

Hospital acquisitions

Health system combinations

Multi-facility transactions

Asset sales

Strategic affiliations

Academic medical center transactions

System consolidations

Disaffiliations

A hospital transaction may affect facility licenses, Medicare and Medicaid participation, payer relationships, medical staff structures, real estate, debt, and tax status.

For nonprofit hospitals, the transaction may also implicate charitable assets, tax-exempt status, public-interest review, and state attorney general oversight.

Acquisitions of physician practices, ambulatory surgery centers, imaging providers, specialty groups, and outpatient clinics can raise ownership and compensation issues that do not arise in a conventional corporate transaction.

The structure may depend on state corporate practice of medicine restrictions, fee-splitting rules, professional-entity ownership, physician employment agreements, management arrangements, referral relationships, and payer participation.

Private equity healthcare transactions often begin with a platform investment followed by add-on or tuck-in acquisitions.

A transaction model should account for:

Physician ownership restrictions

Management-services arrangements

Compensation structures

Reimbursement practices

Regulatory differences across states

Antitrust exposure

Billing and compliance integration

A structure used for one portfolio company may not work for a provider operating under different state ownership or licensing rules.

Hospitals, physicians, health plans, academic institutions, investors, and other providers may use a joint venture or strategic affiliation instead of a complete acquisition.

The transaction documents can address governance, capital contributions, management authority, compensation, referral relationships, exit rights, and responsibility for regulatory compliance.

Federal fraud-and-abuse rules, state ownership laws, antitrust requirements, and tax considerations may also affect the structure.

Healthcare organizations may sell a service line, subsidiary, facility, physician group, or other operating asset without transferring the entire enterprise.

Carve-outs require allocation of contracts, employees, patient data, licenses, liabilities, reimbursement rights, real estate, and shared services. Transition-services arrangements may also be required while the buyer establishes separate clinical or administrative systems.

The parties may consider an asset acquisition, equity purchase, merger, joint venture, affiliation, or another transaction form.

The letter of intent can address:

Purchase price

Transaction structure

Exclusivity

Assumed liabilities

Key assets

Financing

Regulatory conditions

Anticipated closing requirements

Healthcare ownership or licensing restrictions may determine which structure is workable before the parties begin negotiating definitive documents.

A focused legal due diligence review should bring corporate and healthcare regulatory issues into the same workstream.

Key areas can include:

Ownership and governance

Material contracts

Physician compensation

Referral arrangements

Stark Law and Anti-Kickback exposure

Facility and professional licenses

Medicare and Medicaid enrollment

Billing and reimbursement

Payer contracts

Privacy and cybersecurity

Investigations and audits

Employment matters

Litigation

Antitrust exposure

A material problem may affect price, transaction form, representations, indemnification, escrow, closing conditions, or whether the deal proceeds.

The definitive agreement should allocate healthcare-specific liabilities rather than rely only on standard corporate representations.

Negotiated provisions may address regulatory compliance, billing and coding, physician relationships, licensure, reimbursement, privacy incidents, government investigations, indemnification, escrow, and pre-closing remediation.

The agreement should distinguish risks that can be cured before closing from liabilities that may remain with the acquired business afterward.

Closing conditions may include government filings, license actions, payer notices, third-party consents, antitrust clearance, and state healthcare transaction requirements.

The integration plan may need to coordinate:

Compliance programs

Clinical systems

Billing platforms

Cybersecurity controls

Physician contracts

Payer relationships

Workforce policies

Governance

Financial reporting

Responsibility for each regulatory and operational step should be identified before ownership changes.

The federal Stark Law restricts certain physician referrals for designated health services when the physician has a financial relationship with the entity receiving the referral unless an exception applies.

Relevant arrangements can include:

Physician employment

Medical-director agreements

Ownership interests

Equipment or space leases

Service agreements

Compensation methodology

The federal Anti-Kickback Statute separately addresses knowing and willful remuneration intended to induce or reward referrals or federal healthcare program business.

Transaction documents cannot cure every historical compliance issue. Existing referral and compensation arrangements need to be evaluated based on their actual terms and operation.

Hospital and provider acquisitions may trigger CMS change-of-ownership requirements, commonly referred to as CHOW, together with state licensing and enrollment obligations.

CMS's current hospital ownership data distinguishes among CHOW, acquisition or merger, and consolidation transactions. The transaction form can affect Medicare enrollment and provider-agreement consequences. CMS Hospital Change of Ownership data

The parties should identify:

CMS ownership-change requirements

Medicare and Medicaid enrollment actions

Facility and professional licenses

Certificate-of-need requirements where applicable

Payer consents or notices

Reimbursement liabilities

Provider-agreement consequences

These requirements can materially affect both closing mechanics and successor-liability analysis.

State corporate practice of medicine restrictions may limit who can own or control a professional medical practice. Fee-splitting laws can also affect management fees, percentage-based compensation, and other economic arrangements.

These issues are particularly important in physician-practice acquisitions and private equity or MSO structures because permitted ownership and management models differ by state.

Healthcare transactions often involve electronic health records, patient information, cloud systems, vendors, and historical security incidents.

Review may cover:

Prior breaches

Security risk assessments

Access controls

Business associate agreements

Incident-response records

Vendor relationships

Unresolved investigations

Data migration plans

Where privacy exposure is material, a separate HIPAA compliance review may be appropriate.

The FTC and DOJ may analyze market concentration, geographic overlap, referral patterns, payer contracting, competitive alternatives, and likely effects on price, quality, access, or innovation.

Recent enforcement confirms that healthcare merger review extends beyond hospital-to-hospital combinations. In August 2026, the FTC finalized a consent order requiring divestiture of seven ambulatory surgery centers in connection with Ascension Health's proposed $3.9 billion acquisition of AmSurg. FTC Ascension Health-AmSurg final order

Transactions meeting Hart-Scott-Rodino requirements may also require premerger notification. For 2026, the principal size-of-transaction threshold is $133.9 million for transactions closing on or after February 17, 2026. HSR thresholds are adjusted annually and should be checked for the transaction's expected closing date. FTC 2026 HSR thresholds

Transactions presenting competition concerns may require early merger clearance planning.

Hospital competition analysis can extend beyond whether two facilities operate in the same city.

Relevant factors may include:

Inpatient and outpatient overlap

Physician networks

Specialty services

Ambulatory facilities

Referral patterns

Payer negotiations

Alternative providers available to patients

Private equity roll-ups and serial provider acquisitions may also raise questions about concentration created over a series of transactions.

State healthcare transaction regimes can operate independently of federal HSR review.

California law requires Attorney General review and consent for qualifying sales or transfers of nonprofit healthcare facilities, including certain general acute care hospitals and skilled nursing facilities. California nonprofit health facility transaction review

Illinois separately requires health care facilities and provider organizations involved in covered transactions to provide notice to the Attorney General at least 30 days before closing or the transaction's effective date, subject to the statute's specific requirements. Illinois covered health care transaction notice requirements

Depending on the jurisdiction, state review can address competition, access to care, charity care, workforce effects, community benefits, or continuity of services.

Healthcare transactions combine ordinary M&A issues with restrictions involving provider ownership, referrals, reimbursement, licensure, government-program participation, patient information, and competition.

Those requirements can affect who acquires the business, the permissible transaction structure, approvals required before closing, and liabilities that may remain afterward.

Hospital transactions may require review of facility licensing, Medicare participation, medical staff, tax-exempt status, charitable assets, payer contracts, antitrust exposure, privacy, and state transaction approval or notice requirements.

The required review depends on the hospital, transaction structure, and jurisdictions involved.

Regulatory review should begin before the parties lock in the transaction structure or closing timetable.

This is particularly important for hospital consolidation, physician-practice acquisitions, private equity structures, Medicare provider transactions, and deals subject to antitrust or state healthcare transaction review.